Replies to post #7967 on Halozyme Therapeutics Inc (HALO)

[easycomeandgo]

It is a bit peculiar that the thing got to phase III in this trial, a so called “de-risked” point, when it doesn’t sound to be more effective against pemphigus vulgaris than chicken noodle soup, judging by the Argenx release.